Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gestational Trophoblastic Disease 5Rhabdomyosarcoma 4Sarcoma 3Melanoma 3Testicular Neoplasms 1Teratoma, Ovarian 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hydatidiform Mole, Invasive 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Choroid Plexus Neoplasms 1Choriocarcinoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Blast Crisis 1

Interventions

pembrolizumab 2pazopanib 2Sunitinib 2Radiotherapy 2selinexor 1lentiviral minigene vaccine of COVID-19 coronavirus 1ixazomib 1cediranib 1Zoledronic Acid 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Polymerase Chain Reaction 1Nivolumab 1Neoadjuvant Therapy 1Methotrexate 1Ifosfamide 1Gene Expression Profiling 1Gemcitabine 1Epirubicin 1Doxorubicin 1Diathermy 1Dasatinib 1Dactinomycin 1Dacarbazine 1Cisplatin 1Blotting, Western 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Alveolar Soft Part × Dactinomycin × Clear all
NCT04332874 2026-04-23

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
Sarcoma

Sarcoma, Dermatofibrosarcoma, Sarcoma, Alveolar Soft Part, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡